Long-term results of the R-CEOP90 in the treatment of young patients with chemotherapy-naïve diffuse large B cell lymphoma: a phase II study

Leuk Lymphoma. 2014 Oct;55(10):2387-8. doi: 10.3109/10428194.2013.876632.
No abstract available

Publication types

  • Clinical Trial, Phase II
  • Letter

MeSH terms

  • Antibodies, Monoclonal, Murine-Derived / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cyclophosphamide / administration & dosage
  • Epirubicin / administration & dosage
  • Humans
  • Lymphoma, Large B-Cell, Diffuse / drug therapy*
  • Lymphoma, Large B-Cell, Diffuse / mortality
  • Lymphoma, Large B-Cell, Diffuse / pathology
  • Prednisolone
  • Rituximab
  • Treatment Outcome
  • Vincristine / administration & dosage

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Epirubicin
  • Rituximab
  • Vincristine
  • Cyclophosphamide
  • Prednisolone